0002057780-26-000001.txt : 20260217 0002057780-26-000001.hdr.sgml : 20260217 20260217092043 ACCESSION NUMBER: 0002057780-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260217 DATE AS OF CHANGE: 20260217 EFFECTIVENESS DATE: 20260217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Treysta Medical Technologies Inc. CENTRAL INDEX KEY: 0002057780 ORGANIZATION NAME: EIN: 332998159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573652 FILM NUMBER: 26637108 BUSINESS ADDRESS: STREET 1: 3733 NORTHWEST 53RD LANE CITY: GAINESILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 608-770-0658 MAIL ADDRESS: STREET 1: 3733 NORTHWEST 53RD LANE CITY: GAINESILLE STATE: FL ZIP: 32653 D 1 primary_doc.xml X0708 D LIVE 0002057780 Treysta Medical Technologies Inc. 3733 NORTHWEST 53RD LANE GAINESILLE FL FLORIDA 32653 608-770-0658 DELAWARE None None Corporation true 2025 Nathan Zarnstorff 3733 Northwest 53rd Lane Gainesville FL FLORIDA 32653 Executive Officer Director Marcelo Buzzi 3733 Northwest 53rd Lane Gainesville FL FLORIDA 32653 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-01-19 false true true false 0 300000 90000 210000 false 5 0 0 0 Proceeds will be used for working capital, which may include normal compensation for executive officers. false Treysta Medical Technologies Inc. Nathan Zarnstorff Nathan Zarnstorff President and CEO 2026-02-12